203 related articles for article (PubMed ID: 12214932)
1. Parasitological and immunological changes in murine hepatic schistosomiasis before and after praziquantel treatment.
el-Shafei MM; Mattar MA; Afify HA
J Egypt Soc Parasitol; 2002 Aug; 32(2):551-60. PubMed ID: 12214932
[TBL] [Abstract][Full Text] [Related]
2. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice.
Giboda M; Smith JM
J Trop Med Hyg; 1994 Apr; 97(2):98-102. PubMed ID: 8170010
[TBL] [Abstract][Full Text] [Related]
3. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
[TBL] [Abstract][Full Text] [Related]
4. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
5. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz.
Morsy GH
J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
[TBL] [Abstract][Full Text] [Related]
7. Artichoke leaf extract protects liver of Schistosoma mansoni infected mice through modulation of hepatic stellate cells recruitment.
Sharaf El-Deen SA; Brakat RM; Mohamed ASED
Exp Parasitol; 2017 Jul; 178():51-59. PubMed ID: 28552793
[TBL] [Abstract][Full Text] [Related]
8. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
[TBL] [Abstract][Full Text] [Related]
9. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.
Botros SS; Hammam O; Mahmoud M; Bergquist R
APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722
[TBL] [Abstract][Full Text] [Related]
10. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
[TBL] [Abstract][Full Text] [Related]
11. Hepatic and intestinal schistosomiasis after orthotopic liver transplant.
Hoare M; Gelson WT; Davies SE; Curran M; Alexander GJ
Liver Transpl; 2005 Dec; 11(12):1603-7. PubMed ID: 16315308
[TBL] [Abstract][Full Text] [Related]
12. Parasitological, pathological and functional studies on the effects of IFN alpha 2b in murine hepatic schistosomiasis.
Eissa MM; Baddour NM
Southeast Asian J Trop Med Public Health; 2000; 31 Suppl 1():1-7. PubMed ID: 11414437
[TBL] [Abstract][Full Text] [Related]
13. Overview on cysteine protease inhibitors as chemotherapy for Schistosomiasis mansoni in mice and also its effect on the parasitological and immunological profile.
Farid A; Malek AA; Rabie I; Helmy A; El Amir AM
Pak J Biol Sci; 2013 Dec; 16(24):1849-61. PubMed ID: 24517000
[TBL] [Abstract][Full Text] [Related]
14. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
[TBL] [Abstract][Full Text] [Related]
15. Paeoniflorin targets apoptosis and ameliorates fibrosis in murine schistosomiasis mansoni: A novel insight.
Abd El-Aal NF; Hamza RS; Harb O
Exp Parasitol; 2017 Dec; 183():23-32. PubMed ID: 29037782
[TBL] [Abstract][Full Text] [Related]
16. Experimental schistosomal hepatitis: protective effect of coenzyme-Q10 against the state of oxidative stress.
Othman AA; Shoheib ZS; Abdel-Aleem GA; Shareef MM
Exp Parasitol; 2008 Oct; 120(2):147-55. PubMed ID: 18640114
[TBL] [Abstract][Full Text] [Related]
17. Effect of praziquantel treatment on hepatic pathology of Schistosoma mansoni experimentally infected mice.
Khalil HM; Bebars MA; el-Badawy NM; Abdallah HM; Khalil NM; el-Zayyat EA; el-Din Mohamed MS
J Egypt Soc Parasitol; 1995 Apr; 25(1):269-77. PubMed ID: 7602169
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
Barakat R; El Morshedy H
Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of a Brazilian wild rodent isolate of Schistosoma mansoni to praziquantel in mice.
Costa-Silva M; Barros Lde A; Garcia JS; Neves RH; Rodrigues-Silva R; Machado-Silva JR; Maldonado-Júnior A
Exp Parasitol; 2012 Apr; 130(4):394-9. PubMed ID: 22343042
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety.
Navaratnam AM; Sousa-Figueiredo JC; Stothard JR; Kabatereine NB; Fenwick A; Mutumba-Nakalembe MJ
Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):400-7. PubMed ID: 22657533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
